Highlights
About
Human Plasma Derived Products
Omrix Biopharmaceuticals specializes in the development and manufacture of products derived from human plasma. The products are based on patented technology and sold throughout the world. The company's biosurgical line includes hemostatic products designed to control bleeding during surgery. Omrix also makes a line of passive immunotherapy products for patients with immune deficiencies. Omrix operates as part of Johnson & Johnson's Medical Device and Diagnostics Sector, reporting through Ethicon Inc. The company's facilities include a production plant at Tel Hashomer Hospital, a biomanufacturing facility in Har-Hozvim Technology Park, Jerusalem, and an R&D facility located in the Weizmann Science Park of Ness Ziona.
Identity
| Name | Omrix Biopharmaceuticals |
|---|---|
| Slug | omrix-biopharmaceuticals |
| Type / kind | startup |
| Crunchbase ID | omrix-biopharmaceuticals |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7Z47ALDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by Johnson & Johnson on Nov 2008 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Einstein St 14, Nes Ziyyona, Israel |
Web & social
| https://www.linkedin.com/company/52855 |
Classifications
Funding
| Total raised | $4.8M |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}